| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/19/2009 | US20090075889 Iren protein, its preparation and use |
| 03/19/2009 | US20090075871 Modified Thioredoxin |
| 03/19/2009 | US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof |
| 03/19/2009 | US20090075398 Method for Obtaining Antibodies |
| 03/19/2009 | US20090075341 Il-21 antagonists |
| 03/19/2009 | US20090075340 Kir-Binding Agents and Methods of Use Thereof |
| 03/19/2009 | US20090075339 Autophilic antibodies |
| 03/19/2009 | US20090075334 screening for a compound to change binding of ligand polypeptide for the orphan G protein-coupled receptor protein, APJ and a DNA encoding the same; drug screening; used in treating HIV infection, cancer, and various other diseases and disorders |
| 03/19/2009 | US20090075317 Methods and compositions for modulating hepatocyte growth factor activation |
| 03/19/2009 | US20090075302 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075300 Methods and compositions for the detection of cervical disease |
| 03/19/2009 | US20090075297 Mammalian galanin receptors |
| 03/19/2009 | US20090075279 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075278 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075268 Glycoprotein for use in the treatment of hearing loss defects; Inner Ear Supporting Cell Antigen (IESCA) reactive with an autoantibody associated with AISNHL |
| 03/19/2009 | US20090074808 Secreted Streptococcus Pneumoniae Proteins |
| 03/19/2009 | US20090074799 Antibodies to class ii cytokine receptor-7 |
| 03/19/2009 | US20090074798 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 03/19/2009 | US20090074794 for use in the treatment of crohn's and ulcerative colitis; administering a composition comprising an effective amount of at least one isolated mammalian anti-tumor necrosis factor (TNF) antibody comprising at least one variable region comprising SEQ ID NO:7 and 8 |
| 03/19/2009 | US20090074793 High Affinity Human Antibodies to Human IL-4 Receptor |
| 03/19/2009 | US20090074790 Methods for measuring transforming growth factor beta (TGF-beta) receptor signaling activity and uses thereof |
| 03/19/2009 | US20090074788 Antibody Against Periostin, and a Pharmaceutical Composition comprising it for Preventing or Treating a Disease in which Periostin is Involved |
| 03/19/2009 | US20090074784 Treatment of chronic viral diseases with antibodies to costimulating polypeptide of T cells |
| 03/19/2009 | US20090074783 isolated and purified protein produced by a naturally occurring Babesia sp. and an isolated and purified nucleic acid encoding the above protein; use in diagnosing and treating a mammal infected with a Babesia sp. |
| 03/19/2009 | US20090074782 Compositions and Methods for Treating and Diagnosing Cancer |
| 03/19/2009 | US20090074781 Dengue virus peptide vaccine and methods of preparing and using the same |
| 03/19/2009 | US20090074780 Methods of modifying antibodies, and modified antibodies with improved functional properties |
| 03/19/2009 | US20090074779 Neurotrophin-derived peptide sequences |
| 03/19/2009 | US20090074778 human monoclonal or polyclonal antibodies or fragments, that specifically binds to proteins in a blot analysis or enzyme-linked immunosorbent assay; detection of proteins in biological samples |
| 03/19/2009 | US20090074777 Wnt proteins and detection and treatment of cancer |
| 03/19/2009 | US20090074776 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence |
| 03/19/2009 | US20090074774 Fgfr binding peptides |
| 03/19/2009 | US20090074773 Cancer vaccine |
| 03/19/2009 | US20090074770 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof |
| 03/19/2009 | US20090074767 Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof |
| 03/19/2009 | US20090074765 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 03/19/2009 | US20090074762 Therapeutic use of anti-tweak receptor antibodies |
| 03/19/2009 | US20090074760 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant |
| 03/19/2009 | US20090074758 IL-17 receptor a antigen binding proteins |
| 03/19/2009 | US20090074755 Use of panton-valentine leukocidin for treating and preventing staphylococcus infections |
| 03/19/2009 | US20090074752 Surrogate Therapeutic Endpoint For Anti-CTLA-4 Based Immunotherapy Of Disease |
| 03/19/2009 | US20090074748 Immunological control of beta-amyloid levels in vivo |
| 03/19/2009 | US20090074747 Methods and Compositions for Treating Allergic Diseases |
| 03/19/2009 | US20090074730 Novel stem cells, nucleotide sequences and proteins therefrom |
| 03/19/2009 | US20090074728 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| 03/19/2009 | US20090074662 Cancerous Disease modifying antibodies |
| 03/19/2009 | US20090074661 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 03/19/2009 | US20090074660 Human Monoclonal Antibodies To O8E |
| 03/19/2009 | US20090074659 Cancerous disease modifying antibodies |
| 03/19/2009 | US20090074657 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and uses thereof |
| 03/19/2009 | US20090071842 Method of altering the binding specificity of monoclonal antibodies by oxidation-reduction reactions |
| 03/19/2009 | CA2737126A1 Novel p2x7 epitopes |
| 03/19/2009 | CA2699513A1 Gas57 mutant antigens and gas57 antibodies |
| 03/19/2009 | CA2699225A1 Streptococcus pneumoniae vaccines |
| 03/19/2009 | CA2698809A1 Homogeneous antibody populations |
| 03/19/2009 | CA2698382A1 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 03/19/2009 | CA2697193A1 Rationally designed, synthetic antibody libraries and uses therefor |
| 03/19/2009 | CA2696987A1 Hepatitis b pre-s2 nucleic acid |
| 03/19/2009 | CA2693852A1 Humanized anti-fgf19 antagonists and methods using same |
| 03/18/2009 | EP2036985A1 Antibody gene transfer and recombinant AAV therefor |
| 03/18/2009 | EP2036926A2 Single-chain, multiple antigen forming molecule, its manufacture and use |
| 03/18/2009 | EP2035456A1 Production of bispecific antibodies |
| 03/18/2009 | EP2035455A2 Methods for high-throughput screening of cell lines |
| 03/18/2009 | EP2035454A2 Antibodies to sars coronavirus |
| 03/18/2009 | EP2035448A2 Neuroactive fragments of app |
| 03/18/2009 | EP1613350B1 Therapy of autoimmune disease in a patient with an inadequate response to a tnf-alpha inhibitor |
| 03/18/2009 | EP1463942B1 Methods for purifying protein |
| 03/18/2009 | EP1399482B1 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/18/2009 | EP1386167B1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 03/18/2009 | EP1189937B1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 03/18/2009 | EP1068522B1 Helicobacter pylori nap protein |
| 03/18/2009 | EP1021725B1 Early detection of lysosomal storage disorders |
| 03/18/2009 | EP0814834B2 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same |
| 03/18/2009 | CN101389963A Vascular tumor markers |
| 03/18/2009 | CN101389791A Methods for generating and screening fusion protein libraries and uses thereof |
| 03/18/2009 | CN101389756A Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 03/18/2009 | CN101389658A Cytotoxicity mediation of cells evidencing surface expression of cd59 |
| 03/18/2009 | CN101389657A Thymic stromal lymphopoietin (TSLP) antibodies and uses thereof |
| 03/18/2009 | CN101389656A Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 03/18/2009 | CN101389655A Novel collection of hcdr3 regions and uses therefor |
| 03/18/2009 | CN101389654A Novel non-invasive marker for liver disease |
| 03/18/2009 | CN101387646A Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b |
| 03/18/2009 | CN101386864A Nucleic acid molecules encoding a branching enzyme comprising bacteria of the genus neisseria and method for producing alpha-1.6-branched alpha-1, 4-glucanes |
| 03/18/2009 | CN101386650A Method for preparing ppGalNAc-T18 specific polyclonal antibody |
| 03/18/2009 | CN101386649A High-stable anti-helicobacter pylori recombinant VacA specific egg yolk antibody and use thereof |
| 03/18/2009 | CN101386648A Neutralizing monoclonal antibodies against B type botulinum neurotoxin, preparation method and use thereof |
| 03/18/2009 | CN101386647A Monoclonal antibody aiming at 96-118 amino acid sites of group a streptococcus surface protein FbaA |
| 03/18/2009 | CN101386641A Synthetic peptide vaccines for foot-and-mouth disease |
| 03/18/2009 | CN100469887C Carotene synthase gene and uses therefor |
| 03/18/2009 | CN100469882C Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 03/18/2009 | CN100469878C Vascular adhesion molecules and modulation of their function |
| 03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
| 03/17/2009 | US7504485 Immunoglobulin for use in diagnosis, treatment and prevention of arthritic, nervous system, autoimmune and kidney disorders |
| 03/17/2009 | US7504484 Antibodies to the PRO1561 polypeptide |
| 03/17/2009 | US7504479 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 03/17/2009 | US7504378 Viricides; induction immunology response; compounds according to invention specifically inhibit NS3 protease and do not show significant inhibitory activity against other serine proteases such as human leukocyte elastase, porcine pancreatic elastase, bovine pancreatic chymotrypsin, or cysteine proteases |
| 03/17/2009 | US7504256 Process for producing polypeptide |
| 03/17/2009 | US7504254 Hybridomas; monoclonal antibodies do not cross-react with host tissue polysialic acid and pose minimal risk of autoimmune activity; vaccines; mimetics |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504229 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits |